カテゴリ： Grand View Research, アジア太平洋, 医療/バイオ

PoC診断のアジア太平洋市場2023-2030：市場規模、シェア、動向分析

■ 英語タイトル：Asia Pacific Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2023 - 2030

調査会社Grand View Research社が発行したリサーチレポート（データ管理コード：GRV23NVB142）■ 発行会社/調査会社：Grand View Research
■ 商品コード：GRV23NVB142
■ 発行日：2023年10月5日
■ 調査対象地域：アジア太平洋
■ 産業分野：臨床診断
■ ページ数：120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Grand View Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[PoC診断のアジア太平洋市場2023-2030：市場規模、シェア、動向分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

アジア太平洋地域のPoC診断市場の成長と動向
Grand View Research, Inc.の最新調査によると、アジア太平洋地域のPoC診断市場は、2030年までに156億1000万米ドルに達し、年平均成長率は8.1%に達する見込みです。老年人口の増加、即時結果を提供し患者ケアを改善する能力、PACS（画像保存通信システム）やEMR（電子カルテ）の市場浸透率の上昇と相まって、今後6年間の需要を促進する見込みです。また、特に診断分野に関わる熟練スタッフの不足は、ラボの自動化プロセスを促進することで、PoC（ポイント・オブ・ケア）製品の市場浸透率を加速させる見込みです。在宅医療や高齢者向けの医療施設に対する需要の高まりや、外来患者ケアモデルの確立による在院日数の短縮を目指す各国政府の取り組みも、主要な市場要因になると予想されます。

PoC診断の急速な普及は、医療業界全体に分散化の傾向をもたらしています。医療施設や患者は、遠隔地から医療施設にアクセスしたりケータリングを利用したりすることで、早期診断を促し、コストを抑制しようとして、施設の分散化を進めています。さらに、このようなトレンドは、遠隔診断施設や独立型診断施設の設立の引き金にもなっています。

アジア太平洋地域のPOC診断市場レポートハイライト

- 感染症分野は、感染症アプリケーションにおける従来のラボ検査の代替としてのPoC診断の採用増加により、2022年の売上高シェアが最も高く、市場を支配しました。

- がんマーカー分野は、2023年から2030年までの予測期間において最も速いCAGRで成長する見込みです。アジア太平洋地域は、近年がんの有病率が顕著に増加しています。

- 診療所セグメントは、2022年に35%を超える最大の収益シェアを占めました。診療所は、特に遠隔地や医療サービスが行き届いていない地域での医療サービス提供に不可欠です。

- アジア太平洋地域のPoC診断市場は、中国が2022年に40%超の売上シェアを占めました。中国は世界最大の人口を擁し、慢性疾患や感染症の蔓延という顕著な課題に直面しているため、PoC診断に対する需要が高まっています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. アジア太平洋地域のPOC診断市場変数・傾向・範囲
第4章. アジア太平洋地域のPOC診断市場：製品別予測・傾向分析
第5章. アジア太平洋地域のPOC診断市場：最終用途別予測・傾向分析
第6章. アジア太平洋地域のPOC診断市場：地域別予測・傾向分析
第7章. 競争状況

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-Use Outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Asia Pacific Point Of Care Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Point Of Care Diagnostics Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Asia Pacific Point Of Care Diagnostics: Product Estimates & Trend Analysis
4.1. Point Of Care Diagnostics Market: Key Takeaways
4.2. Point Of Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Glucose Testing
4.3.1. Glucose testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Hb1Ac Testing
4.4.1. Hb1Ac testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Coagulation
4.5.1. Coagulation market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Fertility/Pregnancy
4.6.1. Fertility/Pregnancy market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Infectious Diseases
4.7.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.2. HIV POC
4.7.2.1. HIV POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.3. Clostridium Difficile POC
4.7.3.1. Clostridium difficile POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.4. HBV POC
4.7.4.1. HBV POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.5. Pneumonia or Streptococcus Associated Infections
4.7.5.1. Pneumonia or streptococcus associated infections market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.6. Respiratory Syncytial Virus (RSV) POC
4.7.6.1. Respiratory syncytial virus (RSV) POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.7. HPV POC
4.7.7.1. HPV POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.8. Influenza/Flu POC
4.7.8.1. Influenza/Flu POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.9. HCV POC
4.7.9.1. HCV POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.10. MRSA POC
4.7.10.1. MRSA POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.11. TB and Drug-resistant TB POC
4.7.11.1. TB and drug-resistant TB POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.12. HSV POC
4.7.12.1. HSV POC market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.13. COVID-19
4.7.13.1. COVID-19 market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.14. Other Infectious Diseases
4.7.14.1. Other infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Cardiac Markers
4.8.1. Cardiac markers market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Thyroid Stimulating Hormone
4.9.1. Thyroid stimulating hormone market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Hematology
4.10.1. Hematology stimulating hormone market estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Primary Care Systems
4.11.1. Primary care systems market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Decentralized Clinical Chemistry
4.12.1. Decentralized clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Feces
4.13.1. Feces market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Lipid Testing
4.14.1. Lipid testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.15. Cancer Marker
4.15.1. Cancer marker market estimates and forecasts, 2018 to 2030 (USD Million)
4.16. Blood Gas/Electrolytes
4.16.1. Blood gas/electrolytes market estimates and forecasts, 2018 to 2030 (USD Million)
4.17. Ambulatory Chemistry
4.17.1. Ambulatory chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
4.18. Drug Abuse Testing
4.18.1. Drug abuse testing market estimates and forecasts, 2018 to 2030 (USD Million)
4.19. Autoimmune Disease
4.19.1. Autoimmune disease market estimates and forecasts, 2018 to 2030 (USD Million)
4.20. Urinalysis/Nephrology
4.20.1. Urinalysis/Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Asia Pacific Point Of Care Diagnostics Market: End Use Estimates & Trend Analysis
5.1. Point Of Care Diagnostics Market: Key Takeaways
5.2. Point Of Care Diagnostics Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Clinics
5.3.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.2. Physician Office
5.3.2.1. Physician office market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.3. Pharmacy and Retail Clinics
5.3.3.1. Pharmacy and retail clinics market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.4. Non-practice Clinics
5.3.4.1. Non-practice clinics market estimates and forecasts, 2018 to 2030 (USD Million)
5.3.5. Urgent Care Clinics
5.3.5.1. Urgent care clinics market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Home
5.5.1. Home market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Assisted Living Healthcare Facilities
5.6.1. Assisted living healthcare facilities market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Laboratory
5.7.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Asia Pacific Point Of Care Diagnostics Market: Regional Estimates & Trend Analysis
6.1. Regional Outlook
6.2. Point Of Care Diagnostics Market by Region: Key Marketplace Takeaway
6.3. Asia Pacific
6.3.1. China
6.3.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.2. Japan
6.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.3. India
6.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.4. South Korea
6.3.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.5. Australia
6.3.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.6. Thailand
6.3.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.7. New Zealand
6.3.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.8. Singapore
6.3.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
6.3.9. Vietnam
6.3.9.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Market Participant Categorization
7.2.1. Wipro
7.2.1.1. Company Overview
7.2.1.2. Financial performance
7.2.1.3. Product benchmarking
7.2.1.4. Strategic initiatives
7.2.2. ZOE Limited
7.2.2.1. Company Overview
7.2.2.2. Financial performance
7.2.2.3. Product benchmarking
7.2.2.4. Strategic initiatives
7.2.3. Vocalis Health
7.2.3.1. Company Overview
7.2.3.2. Financial performance
7.2.3.3. Product benchmarking
7.2.3.4. Strategic initiatives
7.2.4. DarwinAI
7.2.4.1. Company Overview
7.2.4.2. Financial performance
7.2.4.3. Product benchmarking
7.2.4.4. Strategic initiatives
7.2.5. Biocogniv Inc.
7.2.5.1. Company Overview
7.2.5.2. Financial performance
7.2.5.3. Product benchmarking
7.2.5.4. Strategic initiatives
7.2.6. Laipac Technology Inc.
7.2.6.1. Company Overview
7.2.6.2. Financial performance
7.2.6.3. Product benchmarking
7.2.6.4. Strategic initiatives
7.2.7. Gauss Surgical, Inc.
7.2.7.1. Company Overview
7.2.7.2. Financial performance
7.2.7.3. Product benchmarking
7.2.7.4. Strategic initiatives
7.2.8. Oxford Immune Algorithmics Ltd
7.2.8.1. Company Overview
7.2.8.2. Financial performance
7.2.8.3. Product benchmarking
7.2.8.4. Strategic initiatives
7.2.9. F. Hoffmann-La Roche Ltd.
7.2.9.1. Company Overview
7.2.9.2. Financial performance
7.2.9.3. Product benchmarking
7.2.9.4. Strategic initiatives
7.2.10. QIAGEN
7.2.10.1. Company Overview
7.2.10.2. Financial performance
7.2.10.3. Product benchmarking
7.2.10.4. Strategic initiatives
7.2.11. Danaher
7.2.11.1. Company Overview
7.2.11.2. Financial performance
7.2.11.3. Product benchmarking
7.2.11.4. Strategic initiatives
7.2.12. Beckman Coulter, Inc.
7.2.12.1. Company Overview
7.2.12.2. Financial performance
7.2.12.3. Product benchmarking
7.2.12.4. Strategic initiatives
7.2.13. Radiometer Medical ApS
7.2.13.1. Company Overview
7.2.13.2. Financial performance
7.2.13.3. Product benchmarking
7.2.13.4. Strategic initiatives
7.2.14. HemoCue AB
7.2.14.1. Company Overview
7.2.14.2. Financial performance
7.2.14.3. Product benchmarking
7.2.14.4. Strategic initiatives
7.2.15. BD (Becton, Dickinson, and Company)
7.2.15.1. Company Overview
7.2.15.2. Financial performance
7.2.15.3. Product benchmarking
7.2.15.4. Strategic initiatives
7.2.16. BIOMÉRIEUX
7.2.16.1. Company Overview
7.2.16.2. Financial performance
7.2.16.3. Product benchmarking
7.2.16.4. Strategic initiatives
7.2.17. Abbott
7.2.17.1. Company Overview
7.2.17.2. Financial performance
7.2.17.3. Product benchmarking
7.2.17.4. Strategic initiatives
7.2.18. Siemens Healthcare GmbH
7.2.18.1. Company Overview
7.2.18.2. Financial performance
7.2.18.3. Product benchmarking
7.2.18.4. Strategic initiatives
7.2.19. Zoetis Services LLC
7.2.19.1. Company Overview
7.2.19.2. Financial performance
7.2.19.3. Product benchmarking
7.2.19.4. Strategic initiatives
7.2.20. Abaxis
7.2.20.1. Company Overview
7.2.20.2. Financial performance
7.2.20.3. Product benchmarking
7.2.20.4. Strategic initiatives
7.2.21. Instrumentation Laboratory Company
7.2.21.1. Company Overview
7.2.21.2. Financial performance
7.2.21.3. Product benchmarking
7.2.21.4. Strategic initiatives
7.2.22. Nova Biomedical
7.2.22.1. Company Overview
7.2.22.2. Financial performance
7.2.22.3. Product benchmarking
7.2.22.4. Strategic initiatives
7.2.23. Trividia Health, Inc.
7.2.23.1. Company Overview
7.2.23.2. Financial performance
7.2.23.3. Product benchmarking
7.2.23.4. Strategic initiatives
7.2.24. Quidel Corporation
7.2.24.1. Company Overview
7.2.24.2. Financial performance
7.2.24.3. Product benchmarking
7.2.24.4. Strategic initiatives
7.2.25. Trinity Biotech
7.2.25.1. Company Overview
7.2.25.2. Financial performance
7.2.25.3. Product benchmarking
7.2.25.4. Strategic initiatives
7.2.26. SEKISUI Diagnostics
7.2.26.1. Company Overview
7.2.26.2. Financial performance
7.2.26.3. Product benchmarking
7.2.26.4. Strategic initiatives
7.2.27. Orasure Technologies, Inc.
7.2.27.1. Company Overview
7.2.27.2. Financial performance
7.2.27.3. Product benchmarking
7.2.27.4. Strategic initiatives
7.2.28. Nipro Europe Group Companies
7.2.28.1. Company Overview
7.2.28.2. Financial performance
7.2.28.3. Product benchmarking
7.2.28.4. Strategic initiatives
7.2.29. Spectral Medical Inc.
7.2.29.1. Company Overview
7.2.29.2. Financial performance
7.2.29.3. Product benchmarking
7.2.29.4. Strategic Initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 Asia Pacific point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 3 Asia Pacific point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 4 Asia Pacific point of care diagnostics market, by region, 2018 - 2030 (USD Million)
Table 5 China point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 6 China point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 7 Japan point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 8 Japan point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 9 India point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 10 India point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 11 Australia point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 12 Australia point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 13 Thailand point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 14 Thailand point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 15 New Zealand point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 16 New Zealand point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 17 Singapore point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 18 Singapore point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)
Table 19 Vietnam point of care diagnostics market, by product, 2018 - 2030 (USD Million)
Table 20 Vietnam point of care diagnostics market, by end-use, 2018 - 2030 (USD Million)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • プライマリケアPOC診断の世界市場2023-2030：市場規模、シェア、動向分析
  • 精密医療の世界市場2023-2030：市場規模、シェア、動向分析
  • 心臓バイオマーカーの世界市場2023-2030：市場規模、シェア、動向分析
  • 世界の医療用チューブ市場2023-2030：市場規模、シェア、動向分析
  • 尿路感染症検査の世界市場2023-2030：市場規模、シェア、動向分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GRV23NVB142 )"PoC診断のアジア太平洋市場2023-2030：市場規模、シェア、動向分析" (英文：Asia Pacific Point Of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Infectious Diseases, Glucose Testing, Cardiac Markers), By End-use (Clinics, Home, Hospitals), By Region, And Segment Forecasts, 2023 - 2030)はGrand View Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。